Results 151 to 160 of about 22,616 (177)
Some of the next articles are maybe not open access.
The American surgeon, 1991
Ten patients, seven women and three men, ages 47 to 76 years (mean 58.6 years), treated for adrenal cortical carcinoma between 1971 and 1989, were reviewed. Three (30%) of the tumors were nonfunctioning. The remaining seven (70%) were functioning, six of them occurring in women.
R A, Decker, M E, Kuehner
openaire +1 more source
Ten patients, seven women and three men, ages 47 to 76 years (mean 58.6 years), treated for adrenal cortical carcinoma between 1971 and 1989, were reviewed. Three (30%) of the tumors were nonfunctioning. The remaining seven (70%) were functioning, six of them occurring in women.
R A, Decker, M E, Kuehner
openaire +1 more source
The Netherlands journal of medicine, 2007
Adrenocortical carcinoma is a rare disease with a poor prognosis. Patients can present with a hormonal syndrome or with general symptoms from an abdominal mass. The pathogenesis is unknown. Sometimes the adrenocortical carcinoma is associated with tumour syndromes such as the Beckwith-Wiedemann and Li-Fraumeni syndrome; however, most tumours are ...
C I M, van Ditzhuijsen +2 more
openaire +1 more source
Adrenocortical carcinoma is a rare disease with a poor prognosis. Patients can present with a hormonal syndrome or with general symptoms from an abdominal mass. The pathogenesis is unknown. Sometimes the adrenocortical carcinoma is associated with tumour syndromes such as the Beckwith-Wiedemann and Li-Fraumeni syndrome; however, most tumours are ...
C I M, van Ditzhuijsen +2 more
openaire +1 more source
Bilateral Adrenocortical Carcinoma
Southern Medical Journal, 1967H, Payan, J, Lancaster
openaire +2 more sources
Treatment Differences for Adrenocortical Carcinoma by Race and Insurance Status
Journal of Surgical Research, 2022Simon A Holoubek +2 more
exaly
Management of adrenocortical carcinoma
ANZ Journal of Surgery, 2015Lianne, Thomas +3 more
openaire +2 more sources
Update on Biology and Genomics of Adrenocortical Carcinomas: Rationale for Emerging Therapies.
Endocrine Reviews, 2022Gary D. Hammer +2 more
exaly
Surgical Oncology Clinics of North America, 2023
Lisa Kenney, Marybeth Hughes
openaire +1 more source
Lisa Kenney, Marybeth Hughes
openaire +1 more source